Most Recent Articles by Helen Fosam
The suggestion of bias in the development of dermatology clinical practice guidelines emerging from the study by Checketts and colleagues has attracted several critical responses including methodological flaws, limitations of the OPD as the data source, and data analysis that is inconsistent with the available evidence.
With demonstrated superior efficacy and safety profiles compared with previously used conventional treatment options, the expectation of outcomes with biologic agents is at worst a well-controlled disease, and at best, disease remission.
Although the step-care approach is the current standard of care, this approach is flawed in several ways with respect to achieving optimal outcomes.
The increasing resistance to various anti-infective agents by bacteria and fungi—in particular Staphylococcus aureus, which is responsible for the majority of skin infections—is of particular concern and presents increasing challenges in treating skin and soft tissue infections (SSTIs).
Dermatology Advisor Articles
- Evidence Lacking for Persistence and Effectiveness of Systemic Psoriasis Therapies
- Strong Bidirectional Association Found Between Depression and Alopecia
- Immunosuppressants Associated With Unsatisfactory Outcomes in Atopic Dermatitis
- Molecular Profiles Vary With Age in Atopic Dermatitis
- Johnson & Johnson to Provide Drug Prices in TV Ads
- Aesthetic-Only Neurotoxin Jeuveau Gets FDA Approval
- Turmeric Polyherbal Supplement May Help Reduce Facial Erythema
- Dupilumab Impacts Symptoms of Atopic Dermatitis in Real-Life Setting
- HIDRAdisk Is a Validated Visual Tool to Assess Hidradenitis Suppurativa Burden
- Thermography Helps Diagnose Allergic vs Irritant Contact Dermatitis